NL

Phares Pharmaceutical Research, N.v.

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 11.1



Trademarks = 1

Forward Citations = 249

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Steven Leigh (5 out of 6 patents)

silverMedal Steve Leigh (3 out of 4 patents)

bronzeMedal Mathew Louis Steven Leigh (3 out of 5 patents)

4.  Peter Van Hoogevest (3 out of 8 patents)

5.  Daniel Streich (2 out of 2 patents)

6.  Jacques Quinton (2 out of 2 patents)

7.  Matthew Louis Steven Leigh (1 out of 1 patent)

8.  Mathew L S Leigh (1 out of 1 patent)

9.  Steven Lehigh (1 out of 1 patent)

10.  Peter J Ayres (1 out of 2 patents)

11.  Mathew Louis Leigh (0 patent)

12.  Mathew Louis Leigh (0 patent)

13.  Peter Van Hoogevest (0 patent)

14.  Steve Leigh (0 patent)

15.  Steve Leigh (0 patent)


9 patents:

Company Overview
Phares Pharmaceutical Research, N.v. is a leading pharmaceutical company specializing in research and development of innovative drugs and treatments. With a focus on improving healthcare outcomes and enhancing quality of life, Phares is dedicated to advancing medical knowledge and bringing cutting-edge therapies to patients worldwide. Through collaboration with top scientists and healthcare professionals, Phares strives to make a positive impact on global health.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#31 in

#682 in Netherlands

NL
NL
Forward Citations = 249

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Phares Pharmaceutical Research, N.v.. Retrieved from https://idiyas.com/company/phares-pharmaceutical-research-n-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…